Topic List : Cancer
New class of RNA tumor suppressors identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Researchers receive outstanding investigator awards from National Cancer Institute
Steven Artandi, Laura Attardi and Amato Giaccia will receive up to $600,000 annually for seven years to study cancer processes.
Story of family's tumor donation inspires more donations
With the donated tissue, a Stanford team has created the first cell line and mouse model of diffuse intrinsic pontine glioma, a deadly tumor.
Researchers suss out brain tumors, and therapy response, with new metabolic PET tracer
The Stanford team capitalized on the fact that rapidly dividing cancer cells require vast stores of cellular building blocks and that a key regulatory enzyme helps to control tumor cell metabolism.
Cancer nanotechnology center to receive more than $9 million
The five-year grant is the third award from the National Cancer Institute to fund the Center for Cancer Nanotechnology Excellence in Translational Diagnostics at Stanford.
More than $500,000 for projects on pediatric cancer
The funding from the St. Baldrick’s Foundation supports research to find cures and better treatments for pediatric cancers.
Combination drug therapy shrinks pancreatic tumors in mice
When used together, two drugs that affect the structure and function of DNA blocked the growth of pancreatic tumor cells in mice. Researchers hope the drugs can soon be tested in humans with pancreatic cancer.
Researchers find mutations that contribute to rare blood cancer
Mutations in immune cells prevented their natural death in roughly half of the cell samples from patients with the incurable cancer, and suggest drug targets for the disease.
Researchers link HIV susceptibility to little-understood immune cell class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Team links gene expression, immune system with cancer survival rates
Linking gene expression patterns and immune system response to patient survival rates in nearly 18,000 cases of 39 types of cancers illuminates broad prognostic correlations.